Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKinsey
Mallinckrodt
Colorcon
Harvard Business School

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Rauwolfia serpentina root - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for rauwolfia serpentina root and what is the scope of freedom to operate?

Rauwolfia serpentina root is the generic ingredient in eight branded drugs marketed by Bowman Pharms, Phys Prods Va, Panray, Apothecon, Ferndale Labs, Pal Pak, Bundy, Halsey, Impax Labs, Ivax Sub Teva Pharms, Purepac Pharm, Pvt Form, Solvay, Tablicaps, Valeant Pharm Intl, Watson Labs, and Forest Pharms, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for rauwolfia serpentina root.

Summary for rauwolfia serpentina root
Recent Clinical Trials for rauwolfia serpentina root

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Heart, Lung, and Blood Institute (NHLBI)Phase 3

See all rauwolfia serpentina root clinical trials

Synonyms for rauwolfia serpentina root
(19alpha)-16,17-Didehydro-19-methyl-oxayohimban-16-carboxylic acid methyl ester
(4S,4aR,13bS,14aS)-methyl 4-methyl-
(4S,4aR,13bS,14aS)-methyl 4-methyl-4a,5,7,8,13,13b,14,14a-octahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizine-1-carboxylate
(7aR,8S,11aS,12aS)-8-Methyl-5,6,7a,8,11a,12,12a,13-octahydro-7H-9-oxa-6a,13-diaza-indeno[2,1-a]anthracene-11-carboxylic acid methyl ester
[2,3-a]pyrano[3,4-g]quinolizine-1-carboxylate
16,17-Didehydro-19-methyloxayohimban-16-carboxylic acid methyl ester
19-Epiajmalicine
19b-methyl-16-methoxycarbonyl-16,17-didehydro-oxayohimbane
4-27-00-07927 (Beilstein Handbook Reference)
483-04-5
483A045
4a,5,7,8,13,13b,14,14a-octahydro-4H-indolo
4QJL8OX71Z
AC-20175
AC1L9C1B
ACon1_001630
Ajmalicin
Ajmalicine
Ajmalicine(-Yohimbine)
AJN
AKOS015895125
Alkaloid C
Alkaloid F
Alkaloid II
API0004044
AS-35306
BDBM50030612
BPBio1_000512
BRD-K83028735-001-01-6
BRD-K83028735-003-03-8
BRN 0097268
BSPBio_000464
C09024
C21H24N2O3
CAS-4373-34-6
CAS-6474-90-4
CHEBI:2524
CHEMBL123325
Circolene
Cristanyl
D08470
del.-Yohimbine
delta-Yohimbine
DivK1c_006521
EINECS 207-589-5
GRTOGORTSDXSFK-XJTZBENFSA-N
GTPL8746
Hydrosarpan
KBio1_001465
KBio2_001255
KBio2_003823
KBio2_006391
KBioSS_001255
Lamuran
Lamuran (TN)
LS-15651
LS-187727
MEGxp0_001818
Methyl (19-methyl-16,17-dehydro-18-oxa-3alpha,15alpha,19beta,20beta-yohimban-16-carboxylat)
Methyl (19alpha)-19-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate
methyl (19alpha)-19-methyl-16,17-didehydrooxayohimban-16-carboxylate
methyl (4S,4aR,13bS,14aS)-4-methyl-4a,5,7,8,13,13b,14,14a-octahydro-4H-indolo[2,3-a]pyrano[3,4-g]quinolizine-1-carboxylate
Methyl 16,17-didehydro-19alpha-methyl-18-oxayohimban-16-carboxylat
NCGC00016647-01
NCGC00016647-02
NCGC00016647-03
NCGC00016647-04
NSC 72133
Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-.alpha).-
Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-alpha)-
Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-alpha)- (9CI)
Oxayohimban-16-carboxylicacid, 16,17-didehydro-19-methyl-, methyl ester, (19a)-
Prestwick0_000592
Prestwick1_000592
Prestwick2_000592
Prestwick3_000592
py-Tetrahydroserpentine
Ranitol
Raubaserp
Raubasil
Raubasin
Raubasine
Raubasine (DCF)
Raubasine,(S)
Raumalina
Rauvasan
rauwolfia alkaloid
Sarpan
SC-80963
SCHEMBL309914
SPBio_002683
SpecPlus_000425
Spectrum_000775
Substance II
Tensyl
Tetrahydroserpentine
UNII-4QJL8OX71Z
Vincain
Vincein
Vinceine
W-106052
ZINC53147422

US Patents and Regulatory Information for rauwolfia serpentina root

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 080914-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Tablicaps RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 083867-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Purepac Pharm RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 080842-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Moodys
Mallinckrodt
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.